Peter Radovich currently serves as president and chief operating officer at Mirum where he is responsible for commercial, corporate development, chemistry, manufacturing and controls (CMC), and supply chain. Peter joined Mirum in April 2020 as chief operating officer with more than 20 years of operational experience in the biopharmaceutical industry. Prior to Mirum, he served as executive vice president, operations at Global Blood Therapeutics (GBT) from 2014 to 2020, responsible for technical operations, supply chain, program management and leadership, quality assurance, and commercial strategy and analytics functions. From 2006 to 2014, Peter worked at Onyx Pharmaceuticals, Inc. (now Amgen, Inc.) serving in a variety of roles including vice president, program leadership, as well as commercial and corporate strategy roles. Prior to Onyx, Peter held product marketing positions at Chiron Corporation (now Novartis AG). Peter is also a board member at Rain Therapeutics Inc., a precision oncology company. Peter received an M.B.A. from Washington University in St. Louis and his undergraduate degree in biology and chemistry from Texas Christian University.